{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:53:57Z","timestamp":1784566437444,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Typhoid fever prevention and control efforts are critical in an era of rising antimicrobial resistance among typhoid pathogens. India remains one of the highest typhoid disease burden countries, although a highly efficacious typhoid conjugate vaccine (TCV), prequalified by the World Health Organization in 2017, has been available since 2013. In 2018, the Navi Mumbai Municipal Corporation (NMMC) introduced TCV into its immunization program, targeting children aged 9 months to 14 years in 11 of 22 areas (Phase 1 campaign). We describe the decision making, implementation, and delivery costing to inform TCV use in other settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We collected information on the decision making and campaign implementation in addition to administrative coverage from NMMC and partners. We then used a microcosting approach from the local government (NMMC) perspective, using a new Microsoft Excel\u2013based tool to estimate the financial and economic vaccination campaign costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The planning and implementation of the campaign were led by NMMC with support from multiple partners. A fixed-post campaign was conducted during weekends and public holidays in July\u2013August 2018 which achieved an administrative vaccination coverage of 71% (ranging from\u200546% in high-income to 92% in low-income areas). Not including vaccine and vaccination supplies, the average financial cost and economic cost per dose of TCV delivery were $0.45 and $1.42, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The first public sector TCV campaign was successfully implemented by NMMC, with high administrative coverage in slums and low-income areas. Delivery cost estimates provide important inputs to evaluate the cost-effectiveness and affordability of TCV vaccination through public sector preventive campaigns.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa597","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T03:32:31Z","timestamp":1594783951000},"page":"S172-S178","source":"Crossref","is-referenced-by-count":28,"title":["Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine\u2014Navi Mumbai, India, 2018"],"prefix":"10.1093","volume":"71","author":[{"given":"Kashmira","family":"Date","sequence":"first","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shimpi","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Luby","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaswami","family":"N","sequence":"additional","affiliation":[{"name":"Navi Mumbai Municipal Corporation, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Haldar","sequence":"additional","affiliation":[{"name":"Ministry of Health and Family Welfare, Government of India, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Katkar","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Wannemuehler","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittal","family":"Mogasale","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pallas","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Song","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kunwar","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anagha","family":"Loharikar","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Yewale","sequence":"additional","affiliation":[{"name":"Dr. Yewale Multispecialty Hospital, Navi Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Ahmed","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Horng","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Wilhelm","sequence":"additional","affiliation":[{"name":"Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Bahl","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for South-East Asia, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Harvey","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases\u2013Indian Council for Medical Research, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"World Health Organization, India Country Office, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2020073002272207800_CIT0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"GBD 2017 Typhoid and Paratyphoid Collaborators.","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020073002272207800_CIT0002","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2020073002272207800_CIT0003","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2020073002272207800_CIT0004","doi-asserted-by":"crossref","first-page":"e0007868","DOI":"10.1371\/journal.pntd.0007868","article-title":"Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance","volume":"13","author":"Hooda","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002272207800_CIT0005","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2015.03.102","article-title":"Antimicrobial resistance and management of invasive Salmonella disease","volume":"33(suppl 3)","author":"Kariuki","year":"2015","journal-title":"Vaccine"},{"key":"2020073002272207800_CIT0006","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"key":"2020073002272207800_CIT0007","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciy1111","article-title":"Antibiotic resistance and typhoid","volume":"68","author":"Dyson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002272207800_CIT0008","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1038\/s41467-018-07370-z","article-title":"The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa","volume":"9","author":"Park","year":"2018","journal-title":"Nat Commun"},{"key":"2020073002272207800_CIT0009","doi-asserted-by":"crossref","first-page":"e00105-18","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"key":"2020073002272207800_CIT0010","doi-asserted-by":"crossref","first-page":"e00482-18","DOI":"10.1128\/mBio.00482-18","article-title":"The gathering storm: is untreatable typhoid fever on the way?","volume":"9","author":"Levine","year":"2018","journal-title":"mBio"},{"key":"2020073002272207800_CIT0011","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"2020073002272207800_CIT0012","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: a call for coordinated action","volume":"62(suppl 1)","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020073002272207800_CIT0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/ciy927","article-title":"Revised global typhoid vaccination policy","volume":"68","author":"Bentsi-Enchill","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002272207800_CIT0014","author":"Gavi the Vaccine Alliance"},{"key":"2020073002272207800_CIT0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020073002272207800_CIT0016","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002272207800_CIT0017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0974-777X.192966","article-title":"Acute undifferentiated febrile illness in patients presenting to a tertiary care hospital in South India: clinical spectrum and outcome","volume":"8","author":"Abhilash","year":"2016","journal-title":"J Glob Infect Dis"},{"key":"2020073002272207800_CIT0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijmm.2016.11.006","article-title":"Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998\u20132012","volume":"307","author":"Das","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"2020073002272207800_CIT0019","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12098-010-0196-9","article-title":"Profile of typhoid fever in children from a tertiary care hospital in Chennai-South India","volume":"77","author":"Ganesh","year":"2010","journal-title":"Indian J Pediatr"},{"key":"2020073002272207800_CIT0020","first-page":"351548","article-title":"Surgical audit of patients with ileal perforations requiring ileostomy in a tertiary care hospital in India","volume":"2015","author":"Verma","year":"2015","journal-title":"Surg Res Pract"},{"key":"2020073002272207800_CIT0021","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1093\/infdis\/jiy502","article-title":"A retrospective review of hospital-based data on enteric fever in India, 2014\u20132015","volume":"218","author":"Sur","year":"2018","journal-title":"J Infect Dis"},{"key":"2020073002272207800_CIT0022","doi-asserted-by":"crossref","first-page":"e0204805","DOI":"10.1371\/journal.pone.0204805","article-title":"Community level antibiotic utilization in India and its comparison vis-\u00e0-vis European countries: evidence from pharmaceutical sales data","volume":"13","author":"Farooqui","year":"2018","journal-title":"PLoS One"},{"key":"2020073002272207800_CIT0023","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s13312-018-1444-8","article-title":"Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) recommended immunization schedule (2018-19) and update on immunization for children aged 0 through 18 years","volume":"55","author":"Balasubramanian","year":"2018","journal-title":"Indian Pediatr"},{"key":"2020073002272207800_CIT0024","first-page":"5","article-title":"Enteric fever in children from Navi Mumbai\u2014clinical profile, hematological features, sensitivity patterns and response to antimicrobials","volume":"2","author":"Gavhane","year":"2010","journal-title":"Pediatr Infect Dis"},{"key":"2020073002272207800_CIT0025","author":"DNA India"},{"key":"2020073002272207800_CIT0026","author":"NMMC"},{"key":"2020073002272207800_CIT0027","author":"India COo"},{"key":"2020073002272207800_CIT0028","volume-title":"Immunization essentials\u2014a practical field guide","author":"USAID","year":"2003"},{"key":"2020073002272207800_CIT0029","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/0019-557X.92403","article-title":"Typhoid vaccine: a case for inclusion in national program","volume":"55","author":"Sharma","year":"2011","journal-title":"Indian J Public Health"},{"key":"2020073002272207800_CIT0030","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1016\/S1470-2045(19)30531-5","article-title":"Current status of human papillomavirus vaccination in India\u2019s cervical cancer prevention efforts","volume":"20","author":"Sankaranarayanan","year":"2019","journal-title":"Lancet Oncol"},{"key":"2020073002272207800_CIT0031","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"2020073002272207800_CIT0032","doi-asserted-by":"crossref","first-page":"e0212049","DOI":"10.1371\/journal.pone.0212049","article-title":"The impact of supplementary immunization activities on routine vaccination coverage: an instrumental variable analysis in five low-income countries","volume":"14","author":"Chakrabarti","year":"2019","journal-title":"PLoS One"},{"key":"2020073002272207800_CIT0033","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"2020073002272207800_CIT0034","doi-asserted-by":"crossref","first-page":"e2629","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002272207800_CIT0035","author":"World Bank"},{"key":"2020073002272207800_CIT0036","author":"World Bank"},{"key":"2020073002272207800_CIT0037","volume-title":"Minutes of the meeting of the National Technical Advisory Group on Immunization (NTAGI)","author":"National Technical Advisory Group on Immunization","year":"2016"},{"key":"2020073002272207800_CIT0038","first-page":"594","article-title":"Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts","volume-title":"BMC public health","author":"John","year":"2018"},{"key":"2020073002272207800_CIT0039","author":"World Health Organization"},{"key":"2020073002272207800_CIT0040","author":"Gavi the Vaccine Alliance"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S172\/33546451\/ciaa597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S172\/33546451\/ciaa597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T06:28:13Z","timestamp":1596090493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/Supplement_2\/S172\/5877832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":40,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2020,7,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa597","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,15]]},"published":{"date-parts":[[2020,7,29]]}}}